In addition to its BK channel antagonistic effects, PA inhibited the proliferation of the human triple negative breast cancer MDA-MB-231 cells via the suppression of the total cellular β-catenin levels [22]. The gene discussed is KCNMA1; the disease is triple-negative breast carcinoma.